KaydedilenlerDerginizi ekleyin

Dergiler / Haseki Tıp Bülteni / 2021 / Cilt: 59 - Sayı: 4

Endocan and Asymmetric Dimethylarginine as an Etiological Indicator in the Maternal and Umbilical Cord Serum in Pre-Eclampsia

Nihal INANDİKLİOGLU
Emre BASER
Demet Aydogan KİRMİZİ
Sayfa
308–312
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Likewise, the levels of the umbilical cord and maternal serum endocan were statisticallysignificantly higher in the preeclampsia group compared to the control group (p=0.001, p=0.037, respectively).Conclusion: We found that ADMA and endocan molecules associated with endothelial dysfunction in the pathogenesis of preeclampsiasignificantly increased in maternal and umbilical cord serum

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Aim: Preeclampsia is a pregnancy-specific disease of unknown etiology.
📊
Temel Bulgular & Veri:This study was planned to determine the place of asymmetricdimethylarginine (N, N-dimethylarginine, ADMA) and endothelial cell specific molecule-1 (ESM1, endocan) levels in etiology.
💡
Sonuç & Katkı:Likewise, the levels of the umbilical cord and maternal serum endocan were statisticallysignificantly higher in the preeclampsia group compared to the control group (p=0.001, p=0.037, respectively).Conclusion: We found that ADMA and endocan molecules associated with endothelial dysfunction in the pathogenesis of preeclampsiasignificantly increased in maternal and umbilical cord serum
🔬Tür:Araştırma Makalesi
📍Kapsam:2020 Verileri
⚙️Değişkenler:Alan Parametreleri

Özet

Aim: Preeclampsia is a pregnancy-specific disease of unknown etiology. This study was planned to determine the place of asymmetricdimethylarginine (N, N-dimethylarginine, ADMA) and endothelial cell specific molecule-1 (ESM1, endocan) levels in etiology. The aim ofthis study was to determine ADMA and endocan levels in maternal and fetal umbilical cord serum of patients with preeclampsia andto evaluate them with clinical data.Methods: This case-control study was conducted between June and December 2020. The clinical and demographic characteristics ofthe participants were evaluated in the department of obstetrics and gynecology. Thirty-tree women with preeclampsia and 55 healthywomen in the same age group were included in our study. Serum ADMA and endocan values were determined by the ELISA method.Results: Maternal and umbilical cord ADMA levels in the preeclampsia group were statistically significantly higher than the controlgroup (p=0.001, p=0.001, respectively). Likewise, the levels of the umbilical cord and maternal serum endocan were statisticallysignificantly higher in the preeclampsia group compared to the control group (p=0.001, p=0.037, respectively).Conclusion: We found that ADMA and endocan molecules associated with endothelial dysfunction in the pathogenesis of preeclampsiasignificantly increased in maternal and umbilical cord serum

🔖

Bu Makaleye Atıf Yap

INANDİKLİOGLU, N., BASER, E., KİRMİZİ, D. A. (2021). Endocan and Asymmetric Dimethylarginine as an Etiological Indicator in the Maternal and Umbilical Cord Serum in Pre-Eclampsia. Haseki Tıp Bülteni, Cilt: 59 - Sayı: 4, 308–312. https://ajindex.com/articles/347929

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (14)

  1. Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists’ Task Force on Hypertension in Pregnancy. Obstet Gynecol 2013;122:1122-31
  2. Nirupama R, Divyashree S, Janhavi P, Muthukumar SP, Ravindra PV. Preeclampsia: Pathophysiology and management. J Gynecol Obstet Hum Reprod 2021;50:101975
  3. Böger RH, Vallance P, Cooke JP. Asymmetric dimethylarginine (ADMA): a key regulator of nitric oxide synthase. Atheroscler Suppl 2003;4:1-3
  4. Guerby P, Tasta O, Swiader A, et al. Role of oxidative stress in the dysfunction of the placental endothelial nitric oxide synthase in preeclampsia. Redox Biol 2021;40:101861
  5. Hentschke MR, Lucas LS, Mistry HD, Pinheiro da Costa BE, Poli-de-Figueiredo CE. Endocan-1 concentrations in maternal and fetal plasma and placentae in pre-eclampsia in the third trimester of pregnancy. Cytokine 2015;74:152-6
  6. Leite AR, Borges-Canha M, Cardoso R, Neves JS, CastroFerreira R, Leite-Moreira A. Novel Biomarkers for Evaluation of Endothelial Dysfunction. Angiology 2020;71:397-410
  7. Feng X, Liu Y, Zhang Y, et al. New views on endothelial dysfunction in gestational hypertension and potential therapy targets. Drug Discov Today 2021;26:1420-36
  8. Steegers EA, von Dadelszen P, Duvekot JJ, Pijnenborg R. Preeclampsia. Lancet 2010;376:631-44
  9. Mauro AK, Khurshid N, Berdahl DM, et al. Cytokine concentrations direct endothelial function in pregnancy and preeclampsia. J Endocrinol 2021;248:107-17
  10. Adekola H, Romero R, Chaemsaithong P, et al. Endocan, a putative endothelial cell marker, is elevated in preeclampsia, decreased in acute pyelonephritis, and unchanged in other obstetrical syndromes. J Matern Fetal Neonatal Med 2015;28:1621-32
  11. Cakmak M, Yilmaz H, Bağlar E, et al. Serum levels of endocan correlate with the presence and severity of pre-eclampsia. Clin Exp Hypertens 2016;38:137-42
  12. Cunningham FG. Hypertensive disorders. In: F. Gary Cunningham, Kenneth J. Leveno, Steven L. Bloom, et al. editors. Williams Obstetrics. 24th ed. New York: Mc Graw Hill; 2014. p. 728-79
  13. Pettersson A, Hedner T, Milsom I. Increased circulating concentrations of asymmetric dimethyl arginine (ADMA), an endogenous inhibitor of nitric oxide synthesis, in preeclampsia. Acta Obstet Gynecol Scand 1998;77:808-13
  14. Fickling SA, Williams D, Vallance P, Nussey SS, Whitley GS. Plasma concentrations of endogenous inhibitor of nitric oxide synthesis in normal pregnancy and pre-eclampsia. Lancet 1993;342:242-3